Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001373604-24-000118
Filing Date
2024-12-31
Accepted
2024-12-31 11:13:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 9226
2 BML LETTER TO AADI BOARD bmllettertoaadi.htm EX-1 5405
  Complete submission text file 0001373604-24-000118.txt   16540
Mailing Address 156 S. FIRST STREET ZIONSVILLE IN 46077
Business Address 156 S. FIRST STREET ZIONSVILLE IN 46077 317-344-6689
BML Investment Partners, L.P. (Filed by) CIK: 0001373604 (see all company filings)

EIN.: 383708345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D

Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Subject) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-83932 | Film No.: 241591665
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)